A very sensitive, optimized bioluminescent assay for creatine kinase and creatine kinase MB activities is tested. We evaluated reagent blanks, sensitivity, precision and compared the results with those of the spectrophotometric immunoinhibition test. The main advantage of the new method is a detection limit of less than l U/l which, together with a high precision (s = 0.1 at detection limit), allows determinations of the creatine kinase MB activity even in normal sera in about 20 minutes. A disadvantage of the manual procedure is that it may be necessary to include up to five pipetting Steps.
Introduction
The determination of the activities of creatine kinase 2 ) and its isoenzyme creatine kinase MB is widely used for the detection of muscle cell damage. The activity of the MB isoenzyme is especially valuable in the diagnosis of myocardial infarction (1) . ' The optimized bioluminescent assay for creatine kinase MB activity is based on the backward reaction using creatine phosphate and ADP äs Substrates. Its sensitivity is based on the light-emitting firefly luciferin-luciferase reaction (2) instead of the usual spectrophotometric assay of NADPH. The adenylate kinase problem is circumvented by incorporating inhibitors of adenylate kinase activity (AMP, diadenosine pentaphosphate) into the reaction mixture and by running a blank in which the Substrate creatine phosphate is omitted. The specificity of the assay for creatine kinase MB is based on the specific and total Inhibition of the creatine kinase M subunits by goat anti creatine kinase M antibodies (3) . After Inhibition of all M subunits the residual creatine ki-nasc activity in patients' sera is the rcsult of either crcatine kinase MB, creatine kinase BB or macro creatine kinases. In patients with suspected myocardial infarction this residual creatine kinase activity after immunoinhibition can be regarded s creatine kinase MB activity, because in this group of patients the occurrence of creatine kinase BB (4, 5) or macro creatine kinases (6) is a rare event.
In the following we describe the results of our evaluation of this bioluminescent assay of creatine kinase with fresh and frozen sera. As a reference method we used a mechanized spectrophotometric immunoinhibition assay.
Materials and Methods

Principle
The principle of the bioluminescent assay for the detcrmination of creatine kinase MB is very similar to the spectrophotometric assay. However, apart from the indicator reaction there are other important differences in the concentrations of some reagents: creatine phosphate, N ADP concentrations, and the volume fraction of the sample differ widely in both assays. For details see Total creatine kinase activity Wc measured total creatine kinase activity with the 44 N-acetylcysteine reactivated" kit (No. 14109-141II, E. Merck, Darmstadt, F.R.G.) (7) using an ACP 5040 Instrument (Eppendorf Ger tebau, Hamburg, F.R.G.).
Immunoinhibition test
We determined MB isoenzyme activity with "N-acetylcysteine reactivated" reagents (No. 14109, 14110, 14112, E. Merck, Darmstadt, F.R.G.) using an ACP 5040 Instrument s described elsewhere (6) .
Rcagent blanks
Reagent blanks were determincd by pipetting the same volume of NaCl solution (154 mmol/l) instead of serum.
Influence of 2-mercaptoethanol
We appropriately diluted fresh serum with 154 mmol/l NaCl solution and determined its creatine kinase activity five times. Subsequently another part of this serum was diluted in the same way but simultaneously we added incrcasing amounts of 2-mercaptoethanol (r nge: 0-200 mmol/l). Afterwards the enzyme activities were analysed twice.
Inactivated serum
Heating of normal serum at 56 °C for l h dcstroyed all creatine kinase activity. This serum showed a pH value of 7.45 after heating. Table 2 
Results
Reagent blanks and detection lirnits
assay is greatly influenced by the precision of the ICK and IMB + AK values. The higher the creatine kinase activity the higher is the imprecision of the ICK values determined by the databox. Therefore, imprecision of the assay significantly increased when creatine kinase activities exceeded 50 U/l. At low creatine kinase MB activities we found no marked difference between the results obtained with the two modifications of the calculation procedure (using IMB + AK or ΪΜΒ+ΑΚ). Precision and aceuracy Within-day precision was determined with fresh sera; day-to-day precision was determined with sera which were kept frozen until the day of the assay, Accuracy of the bioluminescent assay may be influenced by serum constituents. This was the case with Seronorm, where it was impossible to reproduce the assigned value for total creatine kinase activity with the bioluminescent assay. The nature of the interfering substance(s) is unknown and the observed influence was not due to urea and creatinine or the electrolytes of this reference material (tab. 4).
Linearity
We checked linearity by pipetting various sample volumes into the reaction mixture. In contrast to the spectrophotometric assay, in the bioluminescent assay the rate of increase of light emission is independent of the final test volume. Therefore doubling the sample volume doubles the resulting enzyme activity. Creatine kinase activity was linearily related to the sample volumes in a ränge of at least 5 to 80 (N = 6; y = 0.17 + 0.67 x; r = 0.999; s y . x = 0.26) and to at least 0-450 U/l (results not shown).
Influence öf 2-mercaptoethanol and of sample dilution
2-Mercaptoethanol:
We evaluated possible interference in the luciferase indicator reaction by the widely used thiol-reagent, 2-mercaptoethanol. Table 5 shows that 2-mercaptoethanol does not affect the total creatine kinase activity. 27; x = 6.5, y = 6,6; there exist no significant differences between x and y, and between fhe slope b and l .00 (t-test, 2 P = 0.99).
x: fresh sera; O: sera storcd trozcn until the day of the assay.
s a function of only one result obtained with the mechanized spectrophotometric assay. Regression analysis (Standard principle component (8)) shows that both methods are in good agreement, even at Iow creatine kinase MB activities. We found no significant differences between fresh and deep-frozen sera.
Cornparison of total creatine kinase activities by bioluminescent and spectrophotometric assays resulted in almost identical values for both methods. Regression analysis (Standard principle component) for sera with enzyme activities between 12 and 450 U/l yielded the following results: N = 42, χ = 114.4, y = 116.8, y = -1.41 + 1.033 x, r = 0.99, s y . x = 8.32. There was no significant difference between χ and y and between the slope b and 1.00 (t-test, 2 P = 0.99).
Discussion
Determination of the MB isoenzyme of creatine kinase by immunoinhibition in sera of patients suspected of having myocardial infarction is commonly accepted. Recently a modification of the spectrophotometric method (3) using firefly-bioluminescence for the indicator reaction was introduced (2) . This is claimed to be more sensitive than the spectrophotometric assay, and therefore capable of wider clinical application.
Our purpose was to evajuate the analytical performance of the new kit, and further, to compare its results with those obtained with the spectrophotometric assay. In order to investigate specific properties of the luciferase System, we usually chose only the easier-to-perform total creatine kinase determination. At this stage of evaluation we were not interê sted in utilizing the high sensitivity of the new system for clinical purposes: e.g. earlier diagnosis of acute myocardial infarction or samples other than serum.
Two steps in the manual bioluminescent assay of total creatine kinase and creatine kinase MB aetivities were found to be critieal: calibration with the internal ATP Standard, and the tinne at which the slopes are measured. This was especially true if the databox was used for calculation of the results. We recommend that the sudden increase of light emission due to the internal calibration (!CK or IMB+AK) be determined after exactly 10 seconds. Otherwise the lag phase of a few seconds ( fig. 1 ) may cause falsely Iow values for ICK or IMB+AK. Furthermore, our experience with creatine kinase activities exceeding 50 U/l showed that it is preferabJe to monitor the slopes due to the creatine kinase reaction for exactly 20 seconds (after a lag phase of 10 seconds) instead of choosing variable measuring times of between 10 and 60 seconds. At shorter intervals creatine kinase activities may be underestimated. This is due to deviations of the linearity of the light emission. At Iow enzyme activities we saw no significant differences in the precisions using either individual ICK and IMB + AK values or the average Ϊ for calculating the enzyme activity. In contrast to published results (2) imprecision slightly increased if the individual ICK values were used, but the differences only became significant at higher creatine kinase activities (tab. 3). In these cases the databox determined the individual ICK or IMB + AK rather imprecisely; reliable enzyme activities then could only be achieved with the average ICK or IMB + AK values. Nevertheless, individual internal calibration by ATP Standards is useful: some_ sera (tab. 4) may contain unknown compounds which strongly interfere with the luciferase indicator reaction, leading to surprisingly Iow ICK values. Only the individual internal calibration can detect such sera and can give an exact result at least for creatine kinase activities up to 40 U/l.
The within-run and day-to-day precisions of the manual bioluminescent assay were high, and at very Iow creatine kinase MB activities its coefficient of Variation was significantly better than the coefficient of Variation of the mechanized spectrophotometric assay. Highly sensitive creatine kinase MB determinations below the upper reference limit are therefore possible. The detection limit of the bioluminescent assay was l U/l, but this result is biased by a reagent blank of 0.7 U/l, a value we determined in all of our lots of reagent. If the bias is compensated for by subtracting the constant reagent blank of 0.7 U/I, then the detection limit is lowered to 0.3 U/l. By increasing the sample volume of the bioluminescent assay the detection limit may be further decreased to about 0.06 U/l.
is well suited to measure creatine kinase MB activit ies in a ränge of below l U/l to at least 450 U/l and therefore fulfills the requirements needed for the diagnosis of myocardial infarction (9) .
Although the concentrations of the Substrates ADP and phosphocreatine äs well äs the concentrations of the adenylate kinase inhibitors are very different in the bioluminescent and spectrophotometric assays, we did not find any discrepancies in the measured enzyme activities for total creatine kinase of for the MB isoenzyme. Even at low creatine kinase MB activities both assays correspond very well, but at creatine kinase MB activities below 10 U/l imprecision of the spectrophotometric assay increases rapidly making comparisons difficult.
In the manual procedure the high sensitivity and precision of the bioluminescent assay for creatine kinase MB necessitates several pipetting Steps and a striet time schedule. A meehanized System shotild circumvent these drawbacks and make the bioluminescent assay suited for routine of stat an^lysesin the laboratory. Diagnostie improvements with respect to earlier confirmation or denial of acute myocardial infarction, which may arise from this highly sensitive assay, have still to be investigated.
